Hu Yan-Ge, Shi Ji-Heng, Yu Da-Xing, Huang Hui-Bin
Department of Emergency, Fuxing Hospital of Capital Medical University, Beijing, China.
Front Nutr. 2025 Jul 23;12:1621206. doi: 10.3389/fnut.2025.1621206. eCollection 2025.
Beta-hydroxy-beta-methylbutyrate (HMB) is a nutritional supplement that has demonstrated favorable effects on restoring muscle mass. However, evidence to support its use in patients underlying surgery remains unclear. We aimed to conduct a systematic review and meta-analysis of HMB in this population to ascertain its effect.
We searched PubMed, EMBASE, Web of Science, the China National Knowledge Infrastructure, Wanfang, and the Cochrane Library for randomized controlled trials (RCTs) focused on surgical patients receiving HMB compared to controls. The last search was March 15, 2025. Length of stay (LOS) and postoperative complications were the primary outcomes. We assessed study quality and performed subgroup analysis, sensitivity analysis, and the GRADE system to explore potential heterogeneity.
Eleven RCTs with 575 patients were included. There are some differences in study design, HMB protocols, and muscle measurements among these trials. Overall, HMB significantly reduced the hospital LOS (MD -0.90 days; 95% CI, -1.79 to -0.01; = 0%, = 0.05) and postoperative complications (RR 0.50; 95% CI, 0.32 to 0.79; = 0%, = 0.003). These findings were confirmed in most subgroup and sensitivity analyses. As to muscle measurements, the HMB group had significantly more mid-arm muscle-circumference ( = 0.05), appendix skeletal muscle mass ( = 0.03) and 6-min walking distances ( = 0.007), but had similar changes in skeletal muscle mass and lean body mass. Regarding nutritional status, compared to the control group, the HMB group did not show significant improvement from baseline after treatment, including body weight, body mass index, serum albumin, and total albumin (-values from 0.10 to 0.63).
HMB supplement seems to significantly improve hospital LOS and postoperative complications, as well as some outcomes of muscle measurements and physical function. However, due to the significantly heterogeneity among the included studies, more well-designed RCTs are needed to confirm our findings.
β-羟基-β-甲基丁酸酯(HMB)是一种营养补充剂,已证明对恢复肌肉质量有积极作用。然而,支持其在手术患者中使用的证据仍不明确。我们旨在对该人群中HMB的使用进行系统评价和荟萃分析,以确定其效果。
我们检索了PubMed、EMBASE、Web of Science、中国知网、万方和Cochrane图书馆,查找与接受HMB的手术患者相比的对照组的随机对照试验(RCT)。最后一次检索时间为2025年3月15日。住院时间(LOS)和术后并发症是主要结局。我们评估了研究质量,并进行了亚组分析、敏感性分析和GRADE系统分析,以探讨潜在的异质性。
纳入了11项RCT,共575例患者。这些试验在研究设计、HMB方案和肌肉测量方面存在一些差异。总体而言,HMB显著缩短了住院时间(MD -0.90天;95%CI,-1.79至-0.01;I² = 0%,P = 0.05)并减少了术后并发症(RR 0.50;95%CI,0.32至0.79;I² = 0%,P = 0.003)。这些结果在大多数亚组和敏感性分析中得到了证实。关于肌肉测量,HMB组的上臂中部肌肉周长(P = 0.05)、附录骨骼肌质量(P = 0.03)和6分钟步行距离(P = 0.007)显著增加,但骨骼肌质量和去脂体重的变化相似。关于营养状况,与对照组相比,HMB组治疗后与基线相比未显示出显著改善,包括体重、体重指数、血清白蛋白和总白蛋白(P值从0.10至0.63)。
补充HMB似乎能显著改善住院时间和术后并发症,以及一些肌肉测量和身体功能的结局。然而,由于纳入研究之间存在显著异质性,需要更多设计良好的RCT来证实我们的发现。